| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.4 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |